Xeljanz (tofacitinib) garnered a lot of interest back in 2012 when it was developed and approved for the treatment of rheumatoid arthritis. Then, in 2017, studies found that this oral medication also treated psoriatic arthritis and FDA approval was added for that indication. Last week, yet another FDA approval for Xeljanz came: this medication now […]
©2020 BioPlus Specialty Pharmacy. All Rights Reserved.